KALA BIO(DE:27F)
€3.400.00 (0.00%)
DE:27F
KALA BIO earnings date
€3.40
At close:0.00 (0.00%)
KALA BIO (27F) Q3 2019 Earnings Report
0 Followers
DE:27F Q3 2019 EPS Results
- Actual EPS
- -EUR 30.84
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 28.58
DE:27F Q3 2019 Revenue Results
- Actual Revenue
- EUR 1.32M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2019
- Date
- 11/07/2019
- Time
- Before Open
- Conference Call
- Thursday, November 7, 2019
Q3 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:27F Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Aug 06, 2026 | 2026 (Q2) | ―-19.34 | -77.56 | 75.07% (+58.22) | |
| May 19, 2026 | 2026 (Q1) | ―-0.12 | -63.95 | 99.81% (+63.83) | |
| Mar 26, 2026 | 2025 (Q4) | -0.290.02 | -1.58 | 101.44% (+1.60) | |
| Nov 17, 2025 | 2025 (Q3) | -0.92-0.92 | -1.75 | 47.67% (+0.83) | |
| Aug 08, 2025 | 2025 (Q2) | -77.26-77.56 | -143.33 | 45.89% (+65.77) | |
| May 14, 2025 | 2025 (Q1) | ―-1.58 | -190.5 | 99.17% (+188.92) | |
| Mar 31, 2025 | 2024 (Q4) | -92.08-63.95 | -190.5 | 66.43% (+126.55) | |
| Nov 12, 2024 | 2024 (Q3) | -110.22-87.54 | -154.67 | 43.40% (+67.13) | |
| Aug 06, 2024 | 2024 (Q2) | -199.80-143.33 | -197.76 | 27.52% (+54.43) | |
| May 14, 2024 | 2024 (Q1) | -131.08-190.50 | -317.05 | 39.91% (+126.55) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
